Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China · Delayed Price · Currency is CNY 78.71
-0.71 (-0.89%)
Jan 23, 2026, 3:00 PM CST
SHA:688399 Market Cap
SHA:688399 has a market cap or net worth of 6.66 billion as of January 22, 2026. Its market cap has increased by 78.23% in one year.
Market Cap
6.66B
Enterprise Value
5.46B
Revenue
339.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
78.71
Market Cap Chart
Since December 5, 2019, SHA:688399's market cap has increased from 3.22B to 6.66B, an increase of 107.05%. That is a compound annual growth rate of 12.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 6.66B | 15.94% |
| Dec 31, 2025 | 5.75B | 54.17% |
| Dec 31, 2024 | 3.73B | 16.52% |
| Dec 29, 2023 | 3.20B | -37.80% |
| Dec 30, 2022 | 5.14B | -36.21% |
| Dec 31, 2021 | 8.06B | -28.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Fengbei Biotech Stock | 7.09B |
| Beijing Konruns Pharmaceutical | 6.94B |
| Xiangxue Pharmaceutical | 6.67B |
| Kexing Biopharm | 6.66B |
| R&G PharmaStudies | 6.66B |
| Shanghai OPM Biosciences | 6.48B |
| PharmaResources (Shanghai) | 6.38B |
| Novogene | 6.08B |